Endogenous estradiol and risk of dementia in women and men: The Rotterdam study

Annals of Neurology

Volumn 53, Issue 5, 2003, Pages 607-615

  Geerlings, Mirjam I ^a,b   Launer, Lenore J ^c   De Jong, Frank H ^a   Ruitenberg, Annemieke ^a   Stijnen, Theo ^a   Van Swieten, John C ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a   Pols, Huibert A P ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; ALZHEIMER DISEASE; COHORT STUDIES; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS;

EID: 0038077567     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10521     Document Type: Article

References (37)

1. Christiansen C, Lindsay R. Estrogens, bone loss and preservation. Osteoporos Int 1990;1:7-13.
2. Hu FB, Grodstein F, Hennekens CH, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999;159:1061-1066.
3. Peters HW, Westendorp ICD, Hak AE, et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med 1999;246:521-528.
4. Gibbs RB, Aggarwal P. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's diseaserelated cognitive decline. Horm Behav 1998;34:98-111.
5. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307.
6. Solerte SB, Fioravanti M, Racchi M, et al. Menopause and estrogen deficiency as a risk factor in dementing illness: hypothesis on the biological basis. Maturitas 1999;31:95-101.
7. Monk D, Brodaty H. Use of estrogens for the prevention and treatment of Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:1-10.
8. Birge SJ. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 1996;44:865-870.
9. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-261.
10. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
11. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996;156:2213-2217.
12. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
13. Baldereschi M, Di Carlo A, Lepore V, et al. Estrogenreplacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 1998;50:996-1002.
14. Waring SC, Rocca WA, Petersen RC, et al. Postmenopausal estrogen replacement therapy and risk of AD: a populationbased study. Neurology 1999;52:965-970.
15. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-695.
16. Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 2000;283:1007-1015.
17. Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 2000;54:295-301.
18. Yaffe K, Grady D, Pressman A, Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc 1998;46:816-821.
19. Barrett-Connor E, Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women. J Am Geriatr Soc 1999;47:1289-1293.
20. Yaffe K, Lui L-Y, Grady D, et al. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 2000;356:708-712.
21. Hofman A, Grobbee DE, de Jong PTVM, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-422.
22. Ott A, Breteler MMB, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam Study. Br Med J 1995;310:970-973.
23. Ott A, Breteler MMB, van Harskamp F, et al. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998;147:574-580.
24. Ruitenberg A, Ott A, van Swieten JC, et al. Incidence of dementia: does gender make a difference? Neurobiol Aging 2001;22:575-580.
25. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
26. Copeland JRM, Kelleher MJ, Kellett JM, et al. A semistructured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability. Psychol Med 1976;6:439-449.
27. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev ed. Washington, DC: American Psychiatric Association, 1987.
29. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
30. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
31. Anatomical Therapeutical Chemical (ATC) Classification Index. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology, 1993.
32. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of casecohort designs. J Clin Epidemiol 1999;52:1165-1172.
33. Södergård R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-810.
34. van den Beld AW, de Jong FH, Grobbee DE, et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000;85:3276-3282.
35. Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, et al. Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire. Eur J Clin Nutr 1998;52:588-596.
36. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994;50:1064-1072.
37. Geerlings MI, Ruitenberg A, Witteman JCM, et al. Reproductive period and risk of dementia in postmenopausal women. JAMA 2001;285:1475-1481.